TODD B. BATES/RUTGERS TODAY
April 5, 2020
NEW BRUNSWICK, NJ - Rutgers’ RUCDR Infinite Biologics has developed a test for the SARS-CoV-2 coronavirus and is using its automation experience and infrastructure to test as many as tens of thousands of samples daily.
"It's a game changer, truly a game changer," said Andrew I. Brooks, chief operating officer and director of technology development at RUCDR Infinite ...
Read More »